{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-016530","form_type":"8-K","ticker":"AIFC","cik":"0000862861","company_name":"AI Financial Corp","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.391178+00:00","generated_at":"2026-05-17T05:11:04.287819+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"confidence":"high","headline":"ALT5 Sigma cancels Alyea spin-off as previously planned; evaluating other strategic options","bullets":["The spin-off of Alyea Therapeutics will not occur with the June 2, 2025 record date as previously disclosed.","The transaction may not proceed under the original timeline; future spin-off or similar transaction remains possible.","Company remains encouraged by Alyea's non-addictive pain treatment patents and potential clinical trial progression.","ALT5 continues to evaluate strategic alternatives to maximize and realize value from Alyea."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-016530","json":"https://secwatch.observer/filing/0001493152-25-016530.json","markdown":"https://secwatch.observer/filing/0001493152-25-016530.md","text":"https://secwatch.observer/filing/0001493152-25-016530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862861/000149315225016530/0001493152-25-016530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862861/000149315225016530/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:11:04.287819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}